Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7199 USD | -2.53% | -2.72% | -12.39% |
Mar. 18 | Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 05 | Camac Partners Provides Information to Shareholders | CI |
Chart calendar Forte Biosciences, Inc.
Upcoming events on Forte Biosciences, Inc.
Past events on Forte Biosciences, Inc.
2024-03-18 04:05 pm | Q4 2023 Earnings Release |
2023-11-13 04:01 pm | Q3 2023 Earnings Release |
2023-09-19 01:00 pm | Annual General Meeting - Proxy Fight for Board Representation |
2023-08-14 04:01 pm | Q2 2023 Earnings Release |
2023-05-15 04:01 pm | Q1 2023 Earnings Release |
2023-03-31 04:05 pm | Q4 2022 Earnings Release |
2022-11-14 04:01 pm | Q3 2022 Earnings Release |
2022-08-15 04:05 pm | Interim 2022 Earnings Release |
2022-06-01 01:00 pm | Annual General Meeting |
2022-05-16 09:00 am | Q1 2022 Earnings Release |
2021-09-07 08:00 am | Interim 2021 Earnings Call |
2021-09-06 | Interim 2021 Earnings Release |
2021-05-27 | Annual General Meeting |
2021-05-10 04:30 pm | Q1 2021 Earnings Call |
2021-05-10 04:05 pm | Q1 2021 Earnings Release |
2021-03-24 08:30 am | FY 2020 Earnings Call |
2021-03-24 08:00 am | FY 2020 Earnings Release |
2021-03-08 01:00 pm | Chardan Microbiome Medicines Summit |
2021-03-01 04:00 pm | Cowen & Co. Health Care Conference |
2020-12-03 11:20 am | Evercore ISI HealthCONx Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | 0,00 | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | 0,00 | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -46,3 -47,6 2.67% | 0,00 | 0,00 | 0,00 0,00 - | -29,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -46,5 -47,6 2.31% | 0,00 | 0,00 | 0,00 0,00 - | 0,00 |
Net income Million USD | Released Forecast Spread | -4,07 | -46,5 -47,6 2.37% | -21,7 | -13,9 | 0,00 0,00 - | 0,00 |
EPS USD | Released Forecast Spread | -0,41 | -6,32 -7,99 20.93% | -1,55 | -0,80 | 0,00 0,00 - | 0,00 |
Announcement Date | 25/03/20 | 16/03/21 | 31/03/22 | 31/03/23 | 18/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q2 | 2022 Q3 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | ||
EBIT Million USD | Released Forecast Spread | -6,52 | -6,91 | -7,55 | -8,04 | -8,22 | |||||
Net income Million USD | Released Forecast Spread | -3,04 | -8,90 | ||||||||
EPS USD | Released Forecast Spread | -0,21 | -0,42 | ||||||||
Announcement Date | 15/08/22 | 14/11/22 | 14/08/23 | 13/11/23 | 18/03/24 | - | - | - | - | - |
Past sector events for Forte Biosciences, Inc.
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- FBRX Stock
- Calendar Forte Biosciences, Inc.